BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/19/2016 4:02:00 PM | Browse: 295 | Download: 234
Publication Name World Journal of Stem Cells
Manuscript ID 27389
Country of Manuscript Source Pakistan
Received
2016-05-27 18:21
Peer-Review Started
2016-05-28 18:25
To Make the First Decision
2016-07-04 15:48
Return for Revision
2016-07-06 08:56
Revised
2016-07-15 04:59
Second Decision
2016-07-28 14:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-08-08 14:40
Articles in Press
2016-08-08 14:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-08-12 17:22
Publish the Manuscript Online
2016-08-19 16:02
ISSN 1948-0210 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Hematology
Manuscript Type Review
Article Title Therapy-related myeloid neoplasms - what have we learned so far?
Manuscript Source Invited Manuscript
All Author List Mohammad Faizan Zahid, Aric Parnes, Bipin N Savani, Mark R Litzow and Shahrukh K Hashmi
Funding Agency and Grant Number
Corresponding author Mohammad Faizan Zahid, MBBS, Medical College, Aga Khan University, P.O. Box 3500, Stadium road, Karachi 74800, Pakistan. faizanzahid91@hotmail.com
Keywords Therapy-related acute myeloid leukemia; Therapy-related myelodysplastic syndromes; Ionizing radiation; Alkylating agents; Allogeneic hematopoietic stem cell transplantation; Topoisomerase Ⅱ inhibitors; Therapy-related myeloid neoplasms
Core Tip Therapy-related myeloid neoplasms are becom-ing an increasing problem as the survival of cancer patients lengthens. The etiology has an important in-fluence on the biological characteristics, time to onset and prognosis of the resultant disease. Although treatment of therapy-related myeloid neoplasms represents a substantial challenge due to prior treatment and comorbidities, cure is possible, especially with allogeneic stem cell transplantation, particularly in those with good-risk karyotype. Ultimately, individual assessment of risk factors may lead to developing risk-adapted therapies to reduce the incidence of this serious complication without affecting therapy for the underlying disorders.
Publish Date 2016-08-19 16:02
Citation Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells 2016; 8(8): 231-242
Url http://www.wjgnet.com/1948-0210/full/v8/i8/231.htm
DOI http://dx.doi.org/10.4252/wjsc.v8.i8.231
Full Article (PDF) WJSC-8-231.pdf
Full Article (Word) WJSC-8-231.doc
Manuscript File 27389-Review.docx
Answering Reviewers 27389-Answering reviewers.pdf
Audio Core Tip 27389-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 27389-Conflict-of-interest statement.pdf
Copyright License Agreement 27389-Copyright assignment.pdf
Peer-review Report 27389-Peer-review(s).pdf
Scientific Misconduct Check 27389-Scientific misconduct check.pdf
Scientific Editor Work List 27389-Scientific editor work list.pdf